» Authors » Osama Y Alshogran

Osama Y Alshogran

Explore the profile of Osama Y Alshogran including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 197
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Altawalbeh S, Sallam N, Al-Khatib M, Alshogran O, Bani Amer M
BMJ Open . 2025 Feb; 15(2):e087232. PMID: 40010830
Objective: Chronic kidney disease (CKD) is associated with a high economic burden, which is exacerbated by the high susceptibility to drug-related problems (DRPs) in this patient population. This study aimed...
2.
Alshogran O, Zhao W, Krans E, Caritis S, Shaik I, Venkataramanan R
Ther Drug Monit . 2024 Dec; PMID: 39671206
Background: Buprenorphine (BUP) use is prevalent in pregnant women with opioid use disorder (OUD). Drug monitoring during pregnancy is critical for optimizing dosing regimen and achieving the desired clinical outcomes....
3.
Khurmah M, Alkhatatbeh M, Alshogran O, Alarda H
Public Health Nurs . 2024 Jul; 41(5):996-1005. PMID: 39037197
Objectives: Our aim was to predict the prevalence of osteopenia and osteoporosis and their associated risk factors among postmenopausal women from Jordan. Methodology: In this cross-sectional study, a total of...
4.
Alshogran O, Dodeja P, Albukhaytan H, Laffey T, Chaphekar N, Caritis S, et al.
Clin Pharmacokinet . 2024 May; 63(5):561-588. PMID: 38748090
Human milk is a remarkable biofluid that provides essential nutrients and immune protection to newborns. Breastfeeding women consuming medications could pass the drug through their milk to neonates. Drugs can...
5.
Jarab A, Al-Alawneh T, Alshogran O, Abu Heshmeh S, Mukattash T, Naser Y, et al.
Antimicrob Resist Infect Control . 2024 Apr; 13(1):35. PMID: 38566242
Background: Antimicrobial stewardship (ASP) is considered a key prevention strategy in addressing the worldwide concern of accelerating antimicrobial resistance. Limited research is available regarding healthcare providers' knowledge and attitude toward...
6.
Zhao W, Alshogran O, Zhang H, Joshi A, Krans E, Caritis S, et al.
J Mass Spectrom . 2024 Mar; 59(4):e5015. PMID: 38501738
Opioid use disorder (OUD) is a chronic neurobehavioral ailment and is prevalent in pregnancy. OUD is commonly treated with methadone or buprenorphine (BUP). Pregnancy is known to alter the pharmacokinetics...
7.
Alshogran O, Al-Shdefat R, Hailat M
J Mass Spectrom . 2023 Nov; 58(12):e4984. PMID: 37950646
Ribociclib is a cyclin-dependent kinase (CDK4/6) inhibitor and is a standard of care for treating metastatic breast cancer. The drug has moderate oral bioavailability and exhibits permeability-controlled absorption. Novel formulations...
8.
Alshogran O, Abdul-Razzak K, Altahrawi A
Int J Clin Pharmacol Ther . 2023 Oct; 61(12):561-571. PMID: 37796147
Objectives: Urinary urgency (UU) is linked to musculoskeletal pain (MSP), and it is associated with mental health conditions. This study examined the prevalence of UU morbidity among outpatients with MSP,...
9.
Khurmah M, Alkhatatbeh M, Alshogran O
Arch Osteoporos . 2023 Sep; 18(1):121. PMID: 37723412
Rationale: Lack of information about osteoporosis knowledge and awareness among premenopausal compared to postmenopausal women in Jordan. Main Result: Women had an average-poor knowledge and awareness about osteoporosis. Significance: This...
10.
Al-Shdefat R, Hailat M, Alshogran O, Dayyih W, Gardouh A, Al Meanazel O
Polymers (Basel) . 2023 Jul; 15(13). PMID: 37447489
Ribociclib is a newly approved orally administered drug for breast cancer. This study aimed to prepare, characterize, and evaluate hybrid lipid-polymer nanoparticles (PLNs) of ribociclib to enhance its in vitro...